Characterisation of Neisseria meningitidis C:2b:P1.2,5 isolates in Poland

Clinical Microbiology and Infection

Volumn 12, Issue 10, 2006, Pages 1027-1030

  Skoczynska A ^a   Kadlubowski M ^a   Wasko I ^b   Hryniewicz, W ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b Centre of Quality Control in Microbiology   (Poland)

Author keywords

MLST; Neisseria meningitidis; Poland; Pulsed field gel electrophoresis; Serogroup C; Typing

Indexed keywords

MENINGOCOCCUS VACCINE; PENICILLIN G;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CARRIER; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH PROMOTION; HUMAN; INFANT; MALE; MASS IMMUNIZATION; MENINGOCOCCOSIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NONHUMAN; POLAND; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

NEISSERIA MENINGITIDIS;

EID: 33748331126     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01554.x     Document Type: Article

References (15)

1. Alcala B, Arreaza L, Salcedo C et al. Capsule switching among C:2B:P1.2,5 meningococcal epidemic strains after mass immunization campaign, Spain. Emerg Infect Dis 2002; 8: 1512-1514.
2. Canica M, Dias R, Ferreira E et al. Neisseria meningitidis C:2B:P1.2,5 with intermediate resistance to penicillin, Portugal. Emerg Infect Dis 2004; 10: 526-529.
3. Stefanelli P, Fazio C, Neri A et al. Emergence in Italy of a Neisseria meningitidis clone with decreased susceptibility to penicillin. Antimicrob Agents Chemother 2004; 48: 3103-3106.
4. Yazdankhah SP, Kriz P, Tzanakaki G et al. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol 2004; 42: 5146-5153.
5. Abdillahi H, Poolman JT. Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 1987; 48: 367-371.
6. Russel JE, Jolley KA, Feavers IM et al. PorA variable regions of Neisseria meningitidis. Emerg Infect Dis 2004; 10: 674-678.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 15th informational supplement. Document M100-S15. Wayne, PA: CLSI, 2005.
8. Verdu ME, Coll P, Fontanals D et al. Endemic meningococcal disease in Cerdanyola, Spain, 1987-93: Molecular epidemiology of the isolates of Neisseria meningitidis. Clin Microbiol Infect 1996; 2: 168-178.
9. Tenover FC, Arbeit RD, Coering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
10. Maiden MC, Bygraves JA, Feil E et al. Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998; 95: 3140-3145.
11. Skoczynska A, Konior R, Sadowy E et al. Identification of Neisseria meningitidis sequence type 66 in Poland. Clin Microbiol Infect 2004; 10: 848-850.
12. Rosenstein NE, Perkins BA, Stephens DS et al. Meningococcal disease. N Engl J Med 2001; 344: 1378-1388.
13. Fangio P, Desbouchages L, Lacherade JC et al. Neisseria meningitidis C:2B:P1.2,5 with decreased susceptibility to penicillin isolated from a patient with meningitis and purpura fulminans. Eur J Clin Microbiol Infect Dis 2005; 24: 140-141.
14. Fernandez S, Arreaza L, Santiago I et al. Carriage of a new epidemic strain of Neisseria meningitidis and its relationship with the incidence of meningococcal disease in Galicia, Spain. Epidemiol Infect 1999; 123: 349-357.
15. Broome CV. The carrier state: Neisseria meningitidis. J Antimicrob Chemother 1986; 18 (suppl A): 25-34.